Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Palladia 50 mg 4 x 5 tabletten

Nr.
1204079
Brand:
Zoetis
Batch:
EN3303
Expiry date:
30-Sep-2023
For the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement
More info

Palladia 50 mg 4 x 5 tabletten

Target species
Dog

Indications
Palladia tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs

Contra-indications
Do not use in dogs used for breeding, or for pregnant or lactating bitches

Route of administration and dosage
Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. PALLADIA may be administered with or without food. Do not split tablets.

More Information
Nr.1204079
Registration numberREG NL 102793
BrandZoetis
Chilled itemNo
Active IngredientToceranib
Target speciesDog
Legal status of supplyUDA
Route of administrationOral
Withdrawal period0 days
BatchEN3303
Expiry dateSep 30, 2023
Units per outer box0
© 2021 Grovet B.V. All rights reserved.